Journal of Korean Academy of Nursing (대한간호학회지)

Korean Society of Nursing Science (한국간호과학회)
권호 표지
DOI QR코드

DOI QR Code

Incidence and Factors Influencing Oral Mucositis in Patients with Hematopoietic Stem Cell Transplantation

조혈모세포이식 환자의 구강 점막염 발생실태와 영향요인

  • Jo, Kwan Suk (Graduate School, The Catholic University of Korea) ;
  • Kim, Nam Cho (College of Nursing, The Catholic University of Korea)
  • Received : 2014.05.09
  • Accepted : 2014.08.21
  • Published : 2014.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: This study was done to examine the incidence of oral mucositis in hematopoietic stem cell transplantation patients and to identify factors influencing oral mucositis and patient outcomes according to severity. Methods: In this retrospective study, data were collected from electronic medical records of 222 patients who had received hematopoietic stem cell transplantation. Oral mucositis was evaluated using WHO's assessment scale. Data were analyzed using Chi-square test, Fisher exact test, Spearman's correlation, Ordinal logistic regression, ANOVA and Kruskal-Wallis test. Results: A total of 69.8% of the patients evaluated developed oral mucositis (grade II and over). As a results of ordinal regression, factors influencing oral mucositis severity were found to be diagnosis, type of transplantation, oxygen inhalation and the number of antiemetics administration before transplantation. The severity of oral mucositis was found to increase the days of hospitalization, days of TPN administration, days of using antibiotics and the number and dosage of analgesics. Conclusion: The results would help predict severity of oral mucositis in hematopoietic stem cell transplantation patients and suggest that provision of appropriate nursing assessment and oral care would improve patient outcomes.

Keywords

References

  1. Larsen J, Nordstrom G, Ljungman P, Gardulf A. Symptom occurrence, symptom intensity, and symptom distress in patients undergoing highdose chemotherapy with stem-cell transplantation. Cancer Nursing. 2004;27(1):55-64. https://doi.org/10.1097/00002820-200401000-00007
  2. Hernandez-Fernandez A, Onate-Sanchez RE, Cabrerizo-Merino MC, de Arriba-de la-Fuente F, Heras-Fernando I, Vicente-Garcia V. Influence of oral health on mucositis in patients undergoing hematopoietic progenitor cell transplantation (HPCT). Medicina Oral, Patologia Oral y Cirugia Bucal. 2012;17(1):e94-e101.
  3. Al-Dasooqi N, Sonis ST, Bowen JM, Bateman E, Blijlevens N, Gibson RJ, et al. Emerging evidence on the pathobiology of mucositis. Supportive Care in Cancer. 2013;21(11):3233-3241. http://dx.doi.org/10.1007/s00520-013-1900-x
  4. Niscola P, Romani C, Cupelli L, Scaramucci L, Tendas A, Dentamaro T, et al. Mucositis in patients with hematologic malignancies: An overview. Haematologica. 2007;92(2):222-231. https://doi.org/10.3324/haematol.10232
  5. Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ. Patient reports of complications of bone marrow transplantation. Supportive Care in Cancer. 2000;8(1):33-39.
  6. Eilers J, Million R. Clinical update: Prevention and management of oral mucositis in patients with cancer. Seminars in Oncology Nursing. 2011;27(4):e1-e16. http://dx.doi.org/10.1016/j.soncn.2011.08.001
  7. Sonis ST. Mucositis: The impact, biology and therapeutic opportunities of oral mucositis. Oral Oncology. 2009;45(12):1015-1020. http://dx.doi.org/10.1016/j.oraloncology.2009.08.006
  8. Vera-Llonch M, Oster G, Ford CM, Lu J, Sonis S. Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies. Supportive Care in Cancer. 2007;15(5):491-496. http://dx.doi.org/10.1007/s00520-006-0176-9
  9. Gabriel DA, Shea T, Olajida O, Serody JS, Comeau T. The effect of oral mucositis on morbidity and mortality in bone marrow transplant. Seminars in Oncology. 2003;30(6 Suppl 18):76-83.
  10. Kashiwazaki H, Matsushita T, Sugita J, Shigematsu A, Kasashi K, Yamazaki Y, et al. A comparison of oral mucositis in allogeneic hematopoietic stem cell transplantation between conventional and reduced-intensity regimens. Supportive Care in Cancer. 2012;20(5):933-939. http://dx.doi.org/10.1007/s00520-011-1164-2
  11. Eilers J. Nursing interventions and supportive care for the prevention and treatment of oral mucositis associated with cancer treatment. Oncology Nursing Forum. 2004;31(4 Suppl):13-23. http://dx.doi.org/10.1188/04.onf.s4.13-23
  12. Ohbayashi Y, Imataki O, Ohnishi H, Iwasaki A, Ogawa T, Inagaki N, et al. Multivariate analysis of factors influencing oral mucositis in allogeneic hematopoietic stem cell transplantation. Annals of Hematology. 2008;87(10):837-845. http://dx.doi.org/10.1007/s00277-008-0508-6
  13. Cheng KK, Lee V, Li CH, Goggins W, Thompson DR, Yuen HL, et al. Incidence and risk factors of oral mucositis in paediatric and adolescent patients undergoing chemotherapy. Oral Oncology. 2011;47(3):153-162. http://dx.doi.org/10.1016/j.oraloncology.2010.11.019
  14. Vokurka S, Bystricka E, Scudlova J, Mazur E, Visokaiova M, Vasilieva E, et al. The risk factors for oral mucositis and the effect of cryotherapy in patients after the BEAM and HD-l-PAM 200 mg/m(2) autologous hematopoietic stem cell transplantation. European Journal of Oncology Nursing. 2011;15(5):508-512. http://dx.doi.org/10.1016/j.ejon.2011.01.006
  15. Park MH, Park JS. Difference of oral mucositis in hospitalized cancer patients receiving chemotherapy. Asian Oncology Nursing. 2013;13(2):76-84. http://dx.doi.org/10.5388/aon.2013.13.2.76
  16. Son YJ, Shin YJ, Cho MY, Kim SH, Park OS, Han SY, et al. The development of an oral care protocol for cancer patients receiving chemotherapy and its effects. Journal of Korean Clinical Nursing Research. 2011;17(1):113-122.
  17. Song CE, So HS, Ju D, Kim EJ. Randomized controlled trial for preventing stomatitis and discomfort among acute leukemic patients. Journal of Korean Oncology Nursing. 2011;11(1):33-40. http://dx.doi.org/10.5388/jkon.2011.11.1.33
  18. Choi SE, Kim HS. Sodium bicarbonate solution versus chlorhexidine mouthwash in oral care of acute leukemia patients undergoing induction chemotherapy: A randomized controlled trial. Asian Nursing Research. 2012;6(2):60-66. https://doi.org/10.1016/j.anr.2012.05.004
  19. Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J, et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. Journal of Clinical Oncology. 2001;19(8):2201-2205. https://doi.org/10.1200/JCO.2001.19.8.2201
  20. Niscola P. Mucositis in malignant hematology. Expert Review of Hematology. 2010;3(1):57-65. http://dx.doi.org/10.1586/ehm.09.71
  21. Strobel ES, Bauchmuller K, Ihorst G, Engelhardt M. Frequency, severity and risk factors for oral mucositis after BEAM conditioning and autologous peripheral blood stem cell transplantation: A single center analysis and review of the literature. Leukemia and Lymphoma. 2007;48(11):2255-2260. http://dx.doi.org/10.1080/10428190701636492
  22. Cheng KK. Association of plasma methotrexate, neutropenia, hepatic dysfunction, nausea/vomiting and oral mucositis in children with cancer. European Journal of Cancer Care. 2008;17(3):306-311. http://dx.doi.org/10.1111/j.1365-2354.2007.00843.x
  23. Vagliano L, Feraut C, Gobetto G, Trunfio A, Errico A, Campani V, et al. Incidence and severity of oral mucositis in patients undergoing haematopoietic SCT-results of a multicentre study. Bone Marrow Transplantation. 2011;46(5):727-732. http://dx.doi.org/10.1038/bmt.2010.184
  24. Barasch A, Peterson DE. Risk factors for ulcerative oral mucositis in cancer patients: Unanswered questions. Oral Oncology. 2003;39(2):91-100. https://doi.org/10.1016/S1368-8375(02)00033-7
  25. Wardley AM, Jayson GC, Swindell R, Morgenstern GR, Chang J, Bloor R, et al. Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue. British Journal of Haematology. 2000;110(2):292-299. https://doi.org/10.1046/j.1365-2141.2000.02202.x
  26. Lalla RV, Sonis ST, Peterson DE. Management of oral mucositis in patients who have cancer. Dental Clinics of North America. 2008;52(1):61-77. http://dx.doi.org/10.1016/j.cden.2007.10.002
  27. Bolwell BJ, Kalaycio M, Sobecks R, Andresen S, Kuczkowski E, Bernhard L, et al. A multivariable analysis of factors influencing mucositis after autologous progenitor cell transplantation. Bone Marrow Transplantation. 2002;30(9):587-591. http://dx.doi.org/10.1038/sj.bmt.1703694
  28. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, et al. Perspectives on cancer therapy-induced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients. Cancer. 2004;100(9 Suppl):1995-2025. http://dx.doi.org/10.1002/cncr.20162
  29. Robien K, Schubert MM, Bruemmer B, Lloid ME, Potter JD, Ulrich CM. Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia. Journal of Clinical Oncology. 2004;22(7):1268-1275. http://dx.doi.org/10.1200/jco.2004.05.147
  30. Saunders DP, Epstein JB, Elad S, Allemano J, Bossi P, van de Wetering MD, et al. Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients. Supportive Care in Cancer. 2013;21(11):3191-3207. http://dx.doi.org/10.1007/s00520-013-1871-y

Cited by

  1. Elimination of unplanned treatment breaks and dose reductions caused by mucositis: Positive implications for survival outcomes and cost reductions using high potency polymerized cross-linked sucralfat vol.13, pp.1, 2014, https://doi.org/10.14216/kjco.17002
  2. Experiences of Unrelated Hematopoietic Stem-cell Donors and Experts of Relevant Institutions vol.31, pp.5, 2014, https://doi.org/10.7475/kjan.2019.31.5.522
  3. Nutritional status as a predictor of adverse events and survival in pediatric autologous stem cell transplant vol.37, pp.8, 2014, https://doi.org/10.1080/08880018.2020.1797254